The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
LLY · Healthcare · Wide moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | LLY | IDXX | GRMN | CORT |
|---|---|---|---|---|
| Moat Score (0–100) | 94 | 96 (highest) | 94 | 92 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 95 (highest) | 90 | 95 (highest) | 71 |
| Pricing power | 99 | 96 | 97 | 100 (highest) |
| Returns on capital | — | 100 (highest) | 100 (highest) | 97 |
| Balance-sheet safety | 83 | 98 | 100 (highest) | 100 (highest) |
| Capital discipline | 100 (highest) | 97 | 77 | 92 |
| Price vs. high estimate | 904% above high estimate | 185% above high estimate | 102% above high estimate (largest discount to high estimate) | 750% above high estimate |
| Market cap | $1.13T | $43.4B | $46.8B | $10.1B |
| Moat tier | Wide moat | Wide moat | Wide moat | Wide moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |